The effect of Noshin Shahd herbal syrup on liver function of patients with alcoholic fatty liver disease
Phase 4
- Conditions
- on-alcoholic fatty liver disease.Fatty (change of) liver, not elsewhere classifiedK76.0
- Registration Number
- IRCT20221216056833N1
- Lead Sponsor
- Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Age between 30 and 65 years
Consistency of exercise program
Body mass index less than 40
Not having a specific disease
Not drinking alcohol
Exclusion Criteria
Performing CABG surgery, occurrence of ASC, heart and brain stroke, pulmonary embolism, deep vein thrombosis or TIA in the last 1 year
Taking anti-inflammatory drugs such as aspirin with an anti-inflammatory dose, antioxidant supplements, vitamins and omega-3 capsules (<1 g/day), and immunosuppressive drugs in the last three months
Presence of cancer, liver and thyroid diseases
pregnancy
alcohol consumption
Taking drugs that lower blood cholesterol and triglycerides
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method iver steatosis level. Timepoint: Before the intervention and 40 days after the intervention. Method of measurement: Fibroscan.
- Secondary Outcome Measures
Name Time Method Serum levels of ALT. Timepoint: Before the intervention and 40 days after the intervention. Method of measurement: Biochemical Autoanalyzor.